Cargando…
New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case–control study in UK general practice
BACKGROUND: Evidence from clinical trial populations suggests low-dose aspirin reduces the risk of colorectal cancer (CRC). Part of this reduction in risk might be due to protection against metastatic disease. METHODS: We investigated the risk of CRC among new-users of low-dose aspirin (75–300 mg),...
Autores principales: | García Rodríguez, Luis A., Soriano-Gabarró, Montse, Bromley, Susan, Lanas, Angel, Cea Soriano, Lucía |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590216/ https://www.ncbi.nlm.nih.gov/pubmed/28882113 http://dx.doi.org/10.1186/s12885-017-3594-9 |
Ejemplares similares
-
Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
por: García Rodríguez, Luis A., et al.
Publicado: (2019) -
Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study
por: García Rodríguez, Luis A., et al.
Publicado: (2020) -
The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice
por: Cea Soriano, Lucía, et al.
Publicado: (2016) -
Validation of low‐dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over‐the‐counter use?
por: Cea Soriano, Lucía, et al.
Publicado: (2015) -
Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK – Results from micro-simulation model()
por: Biccler, Jorne, et al.
Publicado: (2021)